A phase II/III study of JZP-458 in patients with acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL) who are hypersensitive to E. coli-derived asparaginases.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Luke Maese, Rachel E. Rau, Elizabeth A. Raetz, Tong Lin, Pil Kim, Reddy Chandula, Sherrie McClung, Julie Gray, L. Mi Rim Choi, Mignon L. Loh, Peter C. Adamson
Institutions: University of Utah, Huntsman Cancer Institute, Baylor College of Medicine, NYU Langone Health, Jazz Pharmaceuticals (United States), University of California, San Francisco, UCSF Benioff Children's Hospital, UCSF Helen Diller Family Comprehensive Cancer Center, Children's Hospital of Philadelphia
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Jazz Pharmaceuticals
OpenAlex ID: W3030078180